CONNECT BIOPHARMA HLDGS LTD's ticker is CNTB and the CUSIP is 207523101. A total of 15 filers reported holding CONNECT BIOPHARMA HLDGS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $921,590 | -27.5% | 1,125,262 | 0.0% | 0.00% | – |
Q2 2023 | $1,271,546 | +13.0% | 1,125,262 | 0.0% | 0.00% | – |
Q1 2023 | $1,125,149 | +15.2% | 1,125,262 | 0.0% | 0.00% | – |
Q4 2022 | $976,502 | -46.9% | 1,125,262 | -21.1% | 0.00% | – |
Q3 2022 | $1,840,000 | +47.3% | 1,426,428 | -0.6% | 0.00% | – |
Q2 2022 | $1,249,000 | -81.5% | 1,434,960 | -35.8% | 0.00% | – |
Q1 2022 | $6,755,000 | -38.8% | 2,236,392 | +4.3% | 0.00% | – |
Q4 2021 | $11,041,000 | -81.4% | 2,143,760 | -12.5% | 0.00% | -100.0% |
Q3 2021 | $59,366,000 | +23.7% | 2,450,065 | -0.3% | 0.00% | +100.0% |
Q2 2021 | $48,007,000 | +5.9% | 2,458,132 | +0.3% | 0.00% | 0.0% |
Q1 2021 | $45,332,000 | – | 2,450,390 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 597,678 | $771,000 | 0.24% |
Kynam Capital Management, LP | 739,649 | $954,000 | 0.20% |
RA Capital Management | 6,991,003 | $9,018,000 | 0.19% |
Octagon Capital Advisors LP | 450,000 | $581,000 | 0.10% |
Ikarian Capital, LLC | 219,501 | $283,000 | 0.06% |
UBS OCONNOR LLC | 613,931 | $792,000,000 | 0.02% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,277,519 | $1,648,000 | 0.00% |
ROCKY MOUNTAIN ADVISERS, LLC | 1,200 | $2,000 | 0.00% |
CSS LLC/IL | 38,721 | $50,000 | 0.00% |
BOOTHBAY FUND MANAGEMENT, LLC | 26,867 | $35,000 | 0.00% |